bioRxivMicrobiologyPreprint
ESBL plasmid compatibility with the surrounding microbial community influences ESBL gene survival under CRISPR-antimicrobial targeting
Cindy GiveniD, Ilmur JonsdottiriD, Krista Norvasuo, Petra Paananen, Pilvi Ruotsalainen, Teppo HiltuneniD, Marianne GunelliD, Antti HakaneniD, Matti JalasvuoriiD, Reetta K. PenttineniD
Abstract
Bacteria often acquire resistance against antibiotics through the transfer of conjugative resistance plasmids. Hence, it is vital to develop strategies to mitigate the dispersal of antimicrobial resistance (AMR). CRISPR-based antimicrobial tools offer a sequence-specific solution to diminish and restrict the dissemination of antimicrobial resistance genes among bacteria. CRICON (CRISPR via conjugation) is an antimicrobial CRISPR tool that has been shown to efficiently reduce multi-resistance when targeting ESBL (Extended Spectrum Beta-Lactamase) harboring plasmids. However, conjugatively delivered genetic elements may be subjected to bacterial defense, lead to resistance development, and revert the efficiency of the CRISPR tools. Here, we studied the evolutionary consequences of four ESBL-harboring Escherichia coli strains targeted by CRICON in a 10-day multispecies microcosm experiment. We show that CRICON reduces the ESBL prevalence within the bacterial community, while the final ESBL persistence depends on the initial community composition. We observed an unexpected survival strategy of an ESBL-plasmid by escaping into a more competitive host species. Further, we show the development of partial resistance against the CRISPR-antimicrobials during the experiment. Our results underline the importance of the ecological and evolutionary factors in multispecies bacterial communities, as they may disrupt the effective use of CRISPR-based antimicrobial strategies via undesired outcomes of targeted therapies against plasmid-bearing multi-resistant bacteria.
- organism: E. coli
- research focus: host-pathogen & immune response
- research focus: ecology & biodiversity
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Effectiveness of CRISPR-Cas in Sensitizing Bacterial Populations with Plasmid-Encoded Antimicrobial Resistance
Johannes Kippnich, Fabienne Benz, … Franz Baumdicker·GeneticsPeer-reviewed·Sep 23, 2025
- Multi-plasmid clash in a bacterial community: plasmid viability depends on the ecological setting of hosts
C. Given, R. Penttinen, M. Jalasvuori·bioRxiv·Aug 2, 2021
- Prevention of Klebsiella pneumoniae antibiotic resistance plasmid dissemination by prophylactic or simultaneous CRISPR-Cas9 treatment.
Clàudia Morros-Bernaus, Nia Feakes, … David Sünderhauf·bioRxiv·Oct 30, 2026
- Efficacy of plasmid-encoded CRISPR-Cas antimicrobial is affected by competitive factors found in wild Enterococcus faecalis isolates
D. P. Araya, M. Islam, … K. Palmer·bioRxiv·Mar 8, 2022
- Conjugative delivery of CRISPR-Cas9 for the selective depletion of antibiotic-resistant enterococci
M. Rodrigues, S. W. McBride, … B. A. Duerkop·bioRxiv·Aug 27, 2019
- Enterococcus faecalis CRISPR-Cas is a robust barrier to conjugative antibiotic resistance dissemination in the murine intestine
V. J. Price, S. W. McBride, … K. L. Palmer·bioRxiv·May 26, 2019